AAUM (Average Assets Under Management) of ₹517.43 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Auto Components | 10.3% | 13.8% | ▲ +3.5% |
| Industrial Products | 12.4% | 13.7% | ▲ +1.3% |
| Pharmaceuticals & Biotechnology | 26.7% | 13.3% | ▼ -13.4% |
| Chemicals & Petrochemicals | 2.4% | 6.9% | ▲ +4.5% |
| Electrical Equipment | 6.9% | 5.8% | ▼ -1.0% |
| Banks | 4.3% | 5.1% | ▲ +0.8% |
| Healthcare Services | 4.8% | 4.7% | ● -0.1% |
| Automobiles | 2.6% | 3.3% | ▲ +0.7% |
| Consumer Durables | 2.0% | 2.8% | ▲ +0.8% |
| Retailing | 0.0% | 2.8% | ▲ +2.8% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Auto Components | 13.8% | 13.7% | ● -0.1% |
| Pharmaceuticals & Biotechnology | 13.3% | 13.6% | ▲ +0.4% |
| Industrial Products | 13.7% | 13.3% | ▼ -0.4% |
| Chemicals & Petrochemicals | 6.9% | 6.7% | ▼ -0.2% |
| Electrical Equipment | 5.8% | 5.7% | ▼ -0.1% |
| Banks | 5.1% | 4.6% | ▼ -0.4% |
| Healthcare Services | 4.7% | 4.3% | ▼ -0.4% |
| Petroleum Products | 2.7% | 2.8% | ▲ +0.1% |
| Consumer Durables | 2.8% | 2.8% | ● 0.0% |
| Automobiles | 3.3% | 2.7% | ▼ -0.6% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Welspun Corp Limited ₹22.28 Cr |
Industrial Products | 3.66% | 4.11% | +0.45% |
| 2 | Sansera Engineering Limited ₹17.91 Cr |
Auto Components | 2.96% | 3.30% | +0.34% |
| 3 | Shilpa Medicare Ltd ₹16.20 Cr |
Pharmaceuticals & Biotechnology | 2.74% | 2.99% | +0.25% |
| 4 | IOL Chemicals and Pharmaceuticals Limited ₹16.43 Cr |
Pharmaceuticals & Biotechnology | 2.87% | 3.03% | +0.16% |
| 5 | Chennai Petroleum Corporation Limited ₹15.15 Cr |
Petroleum Products | 2.69% | 2.79% | +0.10% |
| 6 | E2E Networks Limited ₹14.46 Cr |
IT - Services | 2.57% | 2.66% | +0.09% |
| 7 | Sai Life Sciences Limited ₹12.80 Cr |
Pharmaceuticals & Biotechnology | 2.29% | 2.36% | +0.07% |
| 8 | Laurus Labs Limited ₹15.30 Cr |
Pharmaceuticals & Biotechnology | 2.76% | 2.82% | +0.06% |
| 9 | Belrise Industries Ltd. ₹14.32 Cr |
Auto Components | 2.58% | 2.64% | +0.06% |
| 10 | Himadri Speciality Chemical Limited ₹12.68 Cr |
Chemicals & Petrochemicals | 2.30% | 2.34% | +0.04% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Ather Energy Limited ₹14.58 Cr |
Automobiles | 3.28% | 2.69% | -0.59% |
| 2 | R R Kabel Limited ₹13.74 Cr |
Industrial Products | 2.98% | 2.53% | -0.45% |
| 3 | The Federal Bank Limited ₹12.76 Cr |
Banks | 2.68% | 2.35% | -0.33% |
| 4 | FSN E-Commerce Ventures Limited ₹13.73 Cr |
Retailing | 2.80% | 2.53% | -0.27% |
| 5 | Apollo Hospitals Enterprise Limited ₹13.78 Cr |
Healthcare Services | 2.80% | 2.54% | -0.26% |
| 6 | Bharat Forge Limited ₹12.64 Cr |
Auto Components | 2.58% | 2.33% | -0.25% |
| 7 | Craftsman Automation Limited ₹14.48 Cr |
Auto Components | 2.91% | 2.67% | -0.24% |
| 8 | Adani Energy Solutions Limited ₹12.03 Cr |
Power | 2.42% | 2.22% | -0.20% |
| 9 | Shaily Engineering Plastics Ltd ₹12.54 Cr |
Industrial Products | 2.50% | 2.31% | -0.19% |
| 10 | Navin Fluorine International Limited ₹14.55 Cr |
Chemicals & Petrochemicals | 2.86% | 2.68% | -0.18% |
35 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹22.28 Cr |
Industrial Products |
4.11%
|
|
| 2 |
₹17.91 Cr |
Auto Components |
3.30%
|
|
| 3 |
₹16.55 Cr |
Electrical Equipment |
3.05%
|
|
| 4 |
₹16.43 Cr |
Pharmaceuticals & Biotechnology |
3.03%
|
|
| 5 |
₹16.20 Cr |
Pharmaceuticals & Biotechnology |
2.99%
|
|
| 6 |
₹15.30 Cr |
Pharmaceuticals & Biotechnology |
2.82%
|
|
| 7 |
₹15.17 Cr |
Auto Components |
2.80%
|
|
| 8 |
₹15.15 Cr |
Petroleum Products |
2.79%
|
|
| 9 |
₹15.09 Cr |
Consumer Durables |
2.78%
|
|
| 10 |
₹14.58 Cr |
Automobiles |
2.69%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.